Published in Curr Med Res Opin on April 01, 2006
Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep (2007) 2.31
Treatment of narcolepsy and other hypersomnias of central origin. Sleep (2007) 1.42
Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc (2009) 1.38
Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev (2013) 1.13
Neurophysiology of sleep and wakefulness: basic science and clinical implications. Curr Neuropharmacol (2008) 1.01
Narcolepsy: a review. Neuropsychiatr Dis Treat (2011) 1.00
Practical use and risk of modafinil, a novel waking drug. Environ Health Toxicol (2012) 0.98
Quality measures for the care of patients with narcolepsy. J Clin Sleep Med (2015) 0.96
Narcolepsy: current treatment options and future approaches. Neuropsychiatr Dis Treat (2008) 0.96
Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol (2015) 0.85
Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea. Sleep Breath (2008) 0.84
Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period. J Clin Sleep Med (2010) 0.83
A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Mayo Clin Proc (2010) 0.82
Complex diagnostic and treatment issues in psychotic symptoms associated with narcolepsy. Psychiatry (Edgmont) (2009) 0.81
Armodafinil in the treatment of sleep/wake disorders. Neuropsychiatr Dis Treat (2010) 0.80
Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans. J Stud Alcohol Drugs (2011) 0.80
Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function. Hum Psychopharmacol (2009) 0.79
The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study. J Clin Sleep Med (2010) 0.79
Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia. Chest (2015) 0.78
Armodafinil-induced wakefulness in animals with ventrolateral preoptic lesions. Nat Sci Sleep (2014) 0.78
Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study. J Clin Sleep Med (2014) 0.78
Diagnosis and management of central hypersomnias. Ther Adv Neurol Disord (2012) 0.77
Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage (2012) 0.77
Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study. Sleep (2016) 0.76
Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue. J Clin Exp Neuropsychol (2013) 0.76
Recognition and management of excessive sleepiness in the primary care setting. Prim Care Companion J Clin Psychiatry (2009) 0.75
Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension. J Clin Sleep Med (2014) 0.75
Healthcare costs among patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy. Am Health Drug Benefits (2014) 0.75
Armodafinil in the treatment of excessive sleepiness. Nat Sci Sleep (2010) 0.75
Modafinil effects on behavior and oxidative damage parameters in brain of wistar rats. Behav Neurol (2014) 0.75
Ready for takeoff? A critical review of armodafinil and modafinil for the treatment of sleepiness associated with jet lag. Nat Sci Sleep (2010) 0.75
History of the development of sleep medicine in the United States. J Clin Sleep Med (2005) 4.22
Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep (2004) 3.78
Sleep loss and REM sleep loss are hyperalgesic. Sleep (2006) 3.03
Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res (2002) 2.99
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry (2006) 2.86
The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res (2006) 2.60
The direct and indirect costs of untreated insomnia in adults in the United States. Sleep (2007) 2.58
Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med (2005) 2.51
Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res (2002) 2.48
Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial. JAMA (2004) 2.36
Strategies for de-identification and anonymization of electronic health record data for use in multicenter research studies. Med Care (2012) 2.30
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology (2002) 2.26
Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep (2007) 2.19
Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic study. Arch Gen Psychiatry (2004) 2.13
Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference. Pediatrics (2006) 2.06
Sleep: a health imperative. Sleep (2012) 2.01
Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation '2003 Sleep in America' Poll. Am J Geriatr Psychiatry (2007) 1.88
The association between obesity and short sleep duration: a population-based study. J Clin Sleep Med (2005) 1.87
The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep (2003) 1.86
Vulnerability to stress-related sleep disturbance and hyperarousal. Sleep (2004) 1.84
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology (2012) 1.83
Insomnia and the performance of US workers: results from the America insomnia survey. Sleep (2011) 1.77
Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev (2001) 1.75
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73
Using difficulty resuming sleep to define nocturnal awakenings. Sleep Med (2010) 1.73
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep (2007) 1.72
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet (2008) 1.72
Laboratory and field studies of naps and caffeine as practical countermeasures for sleep-wake problems associated with night work. Sleep (2006) 1.65
Impact of treatment with continuous positive airway pressure (CPAP) on weight in obstructive sleep apnea. J Clin Sleep Med (2013) 1.55
Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety (2003) 1.54
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS Spectr (2006) 1.53
The Apnea Positive Pressure Long-term Efficacy Study (APPLES): rationale, design, methods, and procedures. J Clin Sleep Med (2006) 1.52
Efficacy and safety of zolpidem extended release in elderly primary insomnia patients. Am J Geriatr Psychiatry (2008) 1.51
Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology (2002) 1.48
Associations of nonrestorative sleep with insomnia, depression, and daytime function. Sleep Med (2010) 1.48
Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol (2005) 1.48
Nocturia and disturbed sleep in the elderly. Sleep Med (2008) 1.47
Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl) (2005) 1.44
Tiredness versus sleepiness: semantics or a target for public education? Sleep (2003) 1.43
Patient-reported outcomes in insomnia: development of a conceptual framework and endpoint model. Behav Sleep Med (2013) 1.43
An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med (2005) 1.42
Caffeine: sleep and daytime sleepiness. Sleep Med Rev (2007) 1.41
The sleep and technology use of Americans: findings from the National Sleep Foundation's 2011 Sleep in America poll. J Clin Sleep Med (2013) 1.41
Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc (2009) 1.38
Diagnosis and treatment of hypothermia. Am Fam Physician (2004) 1.38
Sleep during titration predicts continuous positive airway pressure compliance. Sleep (2003) 1.37
Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia. Sleep Med (2006) 1.37
Sleep and pain: interaction of two vital functions. Semin Neurol (2005) 1.37
Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep (2011) 1.35
The association between obstructive sleep apnea and neurocognitive performance--the Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep (2011) 1.35
The content of medical journal Instructions for authors. Ann Emerg Med (2006) 1.33
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr Med Res Opin (2004) 1.29
Orthostatic hypotension in Parkinson's disease: association with cognitive decline? Int J Geriatr Psychiatry (2006) 1.29
Sleep hygiene practices in a population-based sample of insomniacs. Sleep (2005) 1.26
The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness. Sleep (2010) 1.25
Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). Int J Gen Med (2011) 1.24
A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. Sleep (2005) 1.22
Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry (2004) 1.21
The critical role of sleep spindles in hippocampal-dependent memory: a pharmacology study. J Neurosci (2013) 1.21
Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep (2011) 1.19
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med (2007) 1.17
Ethanol and sleep loss: a "dose" comparison of impairing effects. Sleep (2003) 1.17
The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep (2006) 1.17
Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics (2006) 1.16
Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration. J Clin Pharmacol (2013) 1.16
The association between insomnia severity and healthcare and productivity costs in a health plan sample. Sleep (2011) 1.16
Shift work sleep disorder: burden of illness and approaches to management. Drugs (2006) 1.15
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry (2008) 1.15
Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol (2003) 1.14
A low glycaemic index breakfast cereal preferentially prevents children's cognitive performance from declining throughout the morning. Appetite (2007) 1.14
Zolpidem for insomnia. Expert Opin Pharmacother (2012) 1.14
Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences. Sleep (2008) 1.13
MSLT in primary insomnia: stability and relation to nocturnal sleep. Sleep (2011) 1.13
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. J Clin Psychiatry (2010) 1.13
Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Ann Clin Psychiatry (2008) 1.12
Association of insomnia severity and comorbid medical and psychiatric disorders in a health plan-based sample: Insomnia severity and comorbidities. Sleep Med (2009) 1.10
Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol (2006) 1.09
Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol (2002) 1.09
The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol (2007) 1.08
Reliability and validity of the brief insomnia questionnaire in the America insomnia survey. Sleep (2010) 1.08
Modafinil for excessive sleepiness associated with chronic shift work sleep disorder: effects on patient functioning and health-related quality of life. Prim Care Companion J Clin Psychiatry (2007) 1.08
The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey. Arch Gen Psychiatry (2012) 1.07
Consequences of shiftworking on sleep duration, sleepiness, and sleep attacks. Chronobiol Int (2010) 1.07